M&A Deal Summary

George Clinical Acquires Vector Oncology - CRO Division

On May 2, 2017, George Clinical acquired life science company Vector Oncology - CRO Division from Vector Oncology

Acquisition Highlights
  • This is George Clinical’s 1st transaction in the Life Science sector.
  • This is George Clinical’s 1st transaction in the United States.
  • This is George Clinical’s 1st transaction in Tennessee.

M&A Deal Summary
Date 2017-05-02
Target Vector Oncology - CRO Division
Sector Life Science
Buyer(s) George Clinical
Sellers(s) Vector Oncology
Deal Type Divestiture

Target

Vector Oncology - CRO Division

Memphis, Tennessee, United States
Vector Oncology - CRO Division engages in real world oncology clinical trials, providing a highly focused team of experts in the design and execution of complex oncology specific research. With services that range from protocol generation and detailed study design to completion of complex early phase to late phase oncology programs that span the globe, the group’s focus is to bring speed, quality and expertise to deliver world-class oncology-specific CRO services. With practicing oncologists and continuing access to Vector Oncology’s large streams of retrospective oncology data, we are able to bring real world information sources to the timely completion of studies for our sponsors to the highest scientific standards.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

George Clinical

Newtown, Australia
Category Company
Founded 2005
Sector Life Science
DESCRIPTION

George Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration and post-marketing trials. George Clinical was founded in 2005 and is based in Newtown, Australia.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Tennessee) 1 of 1
Country (United States) 1 of 1
Year (2017) 1 of 1

Seller(S) 1

SELLER

Vector Oncology

Memphis, Tennessee, United States
Category Company
Founded 2002
Sector Life Science
DESCRIPTION

Vector Oncology engages in design and delivery of care based health economics and outcomes (HEOR) oncology research and data analytics. Utilizing our comprehensive Oncology Data Warehouse and proprietary Patient Care Monitor (PCM) patient engagement and outcomes platform we design and deliver high-quality projects generating real world evidence and insight.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Tennessee) 1 of 1
Country (United States) 1 of 1
Year (2017) 1 of 1
Mergr

Product

Company

Legal